Dermatologic adverse events associated with targeted therapies for melanoma.
Abstract
The development of new targeted therapies has considerably changed the therapeutic paradigm of melanoma, significantly increasing overall survival (OS) and progression-free survival (PFS). However, skin-related adverse sequelae might occur and impact on patients' quality of life.In this article we will cover the most important dermatological toxicities related to BRAF and MEK-inhibitors, along with updated management strategies.BRAF inhibitors...
Paper Details
Title
Dermatologic adverse events associated with targeted therapies for melanoma.
Published Date
Mar 1, 2022
Volume
21
Issue
3
Pages
385 - 395
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History